Page last updated: 2024-08-25

bendamustine hydrochloride and Bile Duct Cancer

bendamustine hydrochloride has been researched along with Bile Duct Cancer in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bailey, B; Baumann, F; Caca, K; Chao, Q; Franklin, C; Hennig, L; Patzak, U; Preiss, R; Schoppmeyer, K; Teichert, J1
Caca, K; Kreth, F; Mössner, J; Preiss, R; Schoppmeyer, K; Wiedmann, M1

Trials

1 trial(s) available for bendamustine hydrochloride and Bile Duct Cancer

ArticleYear
A pilot study of bendamustine in advanced bile duct cancer.
    Anti-cancer drugs, 2007, Volume: 18, Issue:6

    Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Bendamustine Hydrochloride; Bile Duct Neoplasms; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Liver Function Tests; Male; Metabolic Detoxication, Phase II; Middle Aged; Neoplasm Staging; Nitrogen Mustard Compounds; Pilot Projects

2007

Other Studies

1 other study(ies) available for bendamustine hydrochloride and Bile Duct Cancer

ArticleYear
Characterization of two phase I metabolites of bendamustine in human liver microsomes and in cancer patients treated with bendamustine hydrochloride.
    Cancer chemotherapy and pharmacology, 2007, Volume: 59, Issue:6

    Topics: Aged; Bendamustine Hydrochloride; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line; Cholangiocarcinoma; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme System; Female; Humans; Male; Microsomes, Liver; Nitrogen Mustard Compounds; Reference Standards

2007